Ignite Creation Date:
2025-12-25 @ 4:32 AM
Ignite Modification Date:
2026-01-22 @ 10:13 PM
Study NCT ID:
NCT00669318
Status:
COMPLETED
Last Update Posted:
2014-07-01
First Post:
2008-04-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-07
Start Date Type:
None
Primary Completion Date:
2013-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-05
Completion Date Type:
ACTUAL
First Submit Date:
2008-04-29
First Submit QC Date:
None
Study First Post Date:
2008-04-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-05-20
Results First Submit QC Date:
None
Results First Post Date:
2014-06-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-06-20
Last Update Post Date:
2014-07-01
Last Update Post Date Type:
ESTIMATED